Psychiatry and Neurology, Neurology · Indianapolis, IN
NPI
1710901277
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1050 Wishard Blvd
Indianapolis, IN, 46202
Phone (317) 274-8800
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
459 services
Medicare patients, 2024
265
Average age 67
Drug cost, 2024
$6.0M
3,282 prescriptions
Company payments, 2025
$432
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert M Pascuzzi was code 99214 (office e&m - established), 95 times for 68 patients. In total Robert M Pascuzzi billed 459 services in 21 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 95 | 68 | $72.10 | $6,850 |
| 99215 Office E&M - Established | Office | 68 | 51 | $124.10 | $8,439 |
| 99214 Office E&M - Established | Facility | 46 | 38 | $60.69 | $2,792 |
| 99215 Office E&M - Established | Facility | 46 | 35 | $94.44 | $4,344 |
| 95886 Electrical Nerve Conductivity | Facility | 44 | 41 | $28.10 | $1,236 |
| 95908 Electrical Nerve Conductivity | Facility | 32 | 31 | $35.61 | $1,139 |
| 95909 Electrical Nerve Conductivity | Facility | 20 | 20 | $49.32 | $986 |
| 99213 Office E&M - Established | Office | 18 | 17 | $47.18 | $849 |
| 99222 Hospital E&M - Initial | Facility | 13 | 13 | $95.68 | $1,244 |
By year: 2022 $32K for 510 services; 2023 $34K for 458 services; 2024 $33K for 459 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert M Pascuzzi prescribed most often to Medicare patients was Gabapentin, with 186 prescriptions and refills. In total Robert M Pascuzzi wrote 3,282 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 186 | 322 | 49 | $4,226 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 167 | 167 | 18 | $4,466 |
| Levetiracetam Generic | 155 | 315 | 39 | $4,090 |
| Clonazepam Generic | 152 | 184 | 21 | $1,266 |
| Pyridostigmine Bromide Generic | 128 | 293 | 38 | $17K |
| Topiramate Generic | 122 | 221 | 29 | $2,677 |
| Prednisone Generic | 106 | 192 | 25 | $706 |
| Diazepam Generic | 101 | 113 | 18 | $1,524 |
| Baclofen Generic | 79 | 151 | 16 | $1,721 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 76 | 136 | 23 | $1,430 |
| Pregabalin Generic | 71 | 100 | 17 | $2,689 |
| Oxcarbazepine Generic | 67 | 122 | 17 | $3,472 |
| Meloxicam Generic | 61 | 77 | Under 11 | $132 |
| Divalproex Sodium Er Divalproex Sodium | 59 | 97 | Under 11 | $4,511 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 55 | 55 | Under 11 | $637K |
Brand drugs: 416 claims; generic drugs: 2,848 claims; opioid claims: 287.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert M Pascuzzi $432 ($432 in general payments such as food, travel and fees) from 2 companies. The largest payer was UCB, Inc. with $347.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.